CD79A and systemic lupus erythematosus: In contrast, cytokine-cytokine receptor interaction, human T-cell leukemia virus 1 infection, systemic lupus erythematosus, and intestinal immune network for IgA production pathways are inhibited in high-risk tumors (Supplementary Table S4).